Literature DB >> 19629507

Obstetric and perinatal outcome in HIV positive women receiving HAART in urban Nigeria.

Biodun N Olagbuji1, Michael Chudi Ezeanochie, Adedapo B Ande, Victor O Oboro.   

Abstract

PURPOSE: To compare the outcome of pregnancy between HIV positive pregnant women on highly active antiretroviral therapy (HAART) and HIV negative controls.
METHODS: A prospective matched case-control study.
RESULTS: HIV positive women were significantly more likely to have anaemia in pregnancy [p < 0.001, odds ratio (95% CI) 5.66 (3.0-10.5)], intrauterine growth restriction [p = 0.002, odds ratio (95%CI) 13.82 (1.8-106.7)], preterm labour [p = 0.03, odds ratio (95% CI) 2.89 (1.2-7.0)] and birth weight less than 2,500 g [p < 0.0001, odds ratio (95% CI) 5.43 (2.4-12.0)]. The 5-min apgar score less than 7, admission into neonatal unit, stillbirth and perinatal mortality were comparable between the two groups.
CONCLUSION: Anaemia in pregnancy, intrauterine growth restriction, preterm labour and birth weight less than 2,500 g are important complications among HIV positive pregnant women. This information is vital for strategic antenatal care planning to improve obstetric and perinatal outcome in these women.

Entities:  

Mesh:

Year:  2009        PMID: 19629507     DOI: 10.1007/s00404-009-1186-x

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  16 in total

Review 1.  Role of the placenta in adverse perinatal outcomes among HIV-1 seropositive women.

Authors:  William Ackerman; Jesse J Kwiek
Journal:  J Nippon Med Sch       Date:  2013       Impact factor: 0.920

Review 2.  Mother-to-child transmission (MTCT) of HIV and drugs of abuse in post-highly active antiretroviral therapy (HAART) era.

Authors:  Vishnudutt Purohit; Rao S Rapaka; David Shurtleff
Journal:  J Neuroimmune Pharmacol       Date:  2010-09-14       Impact factor: 4.147

3.  HIV-AIDS related maternal mortality in Benin City, Nigeria.

Authors:  J U Onakewhor; B N Olagbuji; A B Ande; M C Ezeanochie; O E Olokor; F E Okonofua
Journal:  Ghana Med J       Date:  2011-06

4.  Antiretroviral therapy use during pregnancy and adverse birth outcomes in South African women.

Authors:  Thokozile R Malaba; Tamsin Phillips; Stanzi Le Roux; Kirsty Brittain; Allison Zerbe; Greg Petro; Agnes Ronan; James A McIntyre; Elaine J Abrams; Landon Myer
Journal:  Int J Epidemiol       Date:  2017-10-01       Impact factor: 7.196

5.  Methods of gestational age assessment influence the observed association between antiretroviral therapy exposure, preterm delivery, and small-for-gestational age infants: a prospective study in Cape Town, South Africa.

Authors:  Thokozile Rosemary Malaba; Marie-Louise Newell; Hlengiwe Madlala; Alexander Perez; Clive Gray; Landon Myer
Journal:  Ann Epidemiol       Date:  2018-08-29       Impact factor: 3.797

6.  Mortality and health outcomes in HIV-infected and HIV-uninfected mothers at 18-20 months postpartum in Zomba District, Malawi.

Authors:  Megan Landes; Monique van Lettow; Richard Bedell; Isabell Mayuni; Adrienne K Chan; Lyson Tenthani; Erik Schouten
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

7.  Impact of antiretroviral therapy on fertility desires among HIV-infected persons in rural Uganda.

Authors:  Walter Kipp; Jennifer Heys; Gian S Jhangri; Arif Alibhai; Tom Rubaale
Journal:  Reprod Health       Date:  2011-10-06       Impact factor: 3.223

Review 8.  Association between maternal HIV infection and low birth weight and prematurity: a meta-analysis of cohort studies.

Authors:  Peng-Lei Xiao; Yi-Biao Zhou; Yue Chen; Mei-Xia Yang; Xiu-Xia Song; Yan Shi; Qing-Wu Jiang
Journal:  BMC Pregnancy Childbirth       Date:  2015-10-08       Impact factor: 3.007

Review 9.  HIV and the risk of direct obstetric complications: a systematic review and meta-analysis.

Authors:  Clara Calvert; Carine Ronsmans
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

10.  Infection-related stillbirths.

Authors:  Robert L Goldenberg; Elizabeth M McClure; Sarah Saleem; Uma M Reddy
Journal:  Lancet       Date:  2010-03-09       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.